Correlation Between VanEck Biotech and IShares Consumer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VanEck Biotech and IShares Consumer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VanEck Biotech and IShares Consumer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VanEck Biotech ETF and iShares Consumer Discretionary, you can compare the effects of market volatilities on VanEck Biotech and IShares Consumer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VanEck Biotech with a short position of IShares Consumer. Check out your portfolio center. Please also check ongoing floating volatility patterns of VanEck Biotech and IShares Consumer.

Diversification Opportunities for VanEck Biotech and IShares Consumer

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between VanEck and IShares is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding VanEck Biotech ETF and iShares Consumer Discretionary in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Consumer Dis and VanEck Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VanEck Biotech ETF are associated (or correlated) with IShares Consumer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Consumer Dis has no effect on the direction of VanEck Biotech i.e., VanEck Biotech and IShares Consumer go up and down completely randomly.

Pair Corralation between VanEck Biotech and IShares Consumer

Considering the 90-day investment horizon VanEck Biotech ETF is expected to under-perform the IShares Consumer. In addition to that, VanEck Biotech is 1.61 times more volatile than iShares Consumer Discretionary. It trades about -0.09 of its total potential returns per unit of risk. iShares Consumer Discretionary is currently generating about 0.46 per unit of volatility. If you would invest  8,844  in iShares Consumer Discretionary on August 30, 2024 and sell it today you would earn a total of  852.00  from holding iShares Consumer Discretionary or generate 9.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

VanEck Biotech ETF  vs.  iShares Consumer Discretionary

 Performance 
       Timeline  
VanEck Biotech ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VanEck Biotech ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Etf's fundamental drivers remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders.
iShares Consumer Dis 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Consumer Discretionary are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting basic indicators, IShares Consumer exhibited solid returns over the last few months and may actually be approaching a breakup point.

VanEck Biotech and IShares Consumer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VanEck Biotech and IShares Consumer

The main advantage of trading using opposite VanEck Biotech and IShares Consumer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VanEck Biotech position performs unexpectedly, IShares Consumer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Consumer will offset losses from the drop in IShares Consumer's long position.
The idea behind VanEck Biotech ETF and iShares Consumer Discretionary pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.